Evidence map›Paper›PMID 40153144›Full record

ArticleHormones (Athens, Greece)2025

Functional properties of the γ-ENaC-A635V mutation in a patient with severe hyponatremia.

Marita Antoniadi, Marc Bohnet, Stephan Kellenberger, Dimitra-Irinna Vitoratou, Olga Fafoula, Fani Mylona, Stavroula Kostaridou, Danai Palaiologou, Anna Taliou, Constantine A Stratakis

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Hormones (Athens, Greece), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Marita AntoniadiDepartment of Pediatrics, Penteli Children's Hospital, Athens, Greece. marita_ant@yahoo.gr.ORCID http://orcid.org/0000-0002-5629-9916
Marc BohnetDepartment of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland.
Stephan KellenbergerDepartment of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland.
Dimitra-Irinna VitoratouDepartment of Pediatrics, Penteli Children's Hospital, Athens, Greece.
Olga FafoulaDepartment of Pediatrics, Penteli Children's Hospital, Athens, Greece.
Fani MylonaDepartment of Pediatrics, Penteli Children's Hospital, Athens, Greece.
Stavroula KostaridouDepartment of Pediatrics, Penteli Children's Hospital, Athens, Greece.
Danai PalaiologouGenesis Genoma Lab, Genetic Diagnosis, Clinical Genetics and Research, Athens, Greece.
Anna TaliouSchool of Medicine, National and Kapodistrian University, Athens, Greece.
Constantine A StratakisUnit on Hypothalamic and Pituitary Disorders, Eunice Kennedy Shriver National Institute of Child Health, and Human Development, National Institutes of Health, Bethesda, Maryland, USA.

Funding

Swiss National Science Foundation 310030_207878
6 · The paper itself

Abstract

backgroundAldosterone plays a critical role in sodium homeostasis by binding to the mineralocorticoid receptor promoting sodium retention. It increases the expression of epithelial sodium channels (ENaC) and sodium-potassium ATPases in the renal distal tubules and collecting ducts. Defects in aldosterone synthesis lead to hyponatremia, hyperkalemia, hyperreninemia, metabolic acidosis, and hypovolemia. PATIENT: We present a 7-year-old boy with holoprosencephaly, dysmorphic features, and short stature presenting with persistent hyponatremia since birth and occasional hypokalemia and hyporeninemia. Initial whole exome sequencing (WES) identified a novel in-frame SHH variant, NM_000193.4:c.755_757del (p.Phe252del); possible aldosterone deficiency due to adrenocortical hypoplasia caused by the SHH variant did not fully explain the patient's clinical presentation, prompting further investigation.

resultsDeep analysis of the WES data revealed a second variant of unknown significance in the SCNN1G gene affecting the γ-ENaC subunit, namely NM_001039.4.1904 C > T (p.Ala635Val), which was previously unreported in association with a clinical phenotype. Electrophysiological studies of the amiloride-sensitive current before and after trypsin exposure showed that the γ-ENaC-A635V mutation reduced the amiloride-sensitive sodium current by approximately 30%. The trypsin experiments suggested a lower channel open probability and a reduced inward sodium current through the ENaC.

conclusionsThese findings indicate that the A635 residue participates in channel function, with γ-Α635V leading to decreased sodium reabsorption. This case underscores the importance of reevaluating genetic data to understand complex clinical presentations and identifies a new potential pathogenic variant affecting sodium homeostasis. The case illustrates how genetic variants with contrasting effects on a physiological loop along with functional changes due to development and age may be hard to interpret.

Indexed as

Epithelial Sodium ChannelsHyponatremiaMutationChildHumansMaleEpithelial Sodium ChannelsSCNN1G protein, humanAldosteroneENaCHyponatremiaPseudohypoaldosteronismSodium

Identifiers

PMID40153144

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.